An experiment in end-of-life care: Tapping AI’s cold calculus to nudge the most human of conversations
https://www.statnews.com/2020/07/01/end-of-life-artificial-intelligence/
https://www.statnews.com/2020/07/01/end-of-life-artificial-intelligence/
https://www.newswire.com/news/cancer-care-associates-of-york-joins-the-quality-cancer-care-alliances-21160679
https://www.ncbi.nlm.nih.gov/pubmed/30487236 Drilon A, Fu S, Patel MR, Fakih M, Wang D, Olszanski AJ, Morgensztern D, Liu SV, Cho BC, Bazhenova L, Rodriguez CP, Doebele RC,… A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105.
https://www.biosimilardevelopment.com/doc/aligning-with-cancer-centers-to-spur-biosimilar-uptake-0001
Barkley R1, Soobader MJ2, Wang J2, Blau S3, Page RD4.https://www.ncbi.nlm.nih.gov/pubmed/30576262
https://www.journalofclinicalpathways.com/commentary/what-data-science-addressing-uncertainty-behind-addressing-uncertainty
https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e18098
Author: Kathy Oubre, MS https://www.ajmc.com/journals/evidence-based-oncology/2019/december-2019/empower-physicians-to-fight-financial-toxicity-with-biosimilars
Slamon DJ1, Neven P1, Chia S1, Fasching PA1, De Laurentiis M1, Im SA1, Petrakova K1, Val Bianchi G1, Esteva FJ1, Martín M1, Nusch A1, Sonke GS1, De la Cruz-Merino L1, Beck JT1, Pivot X1, Sondhi M1, Wang Y1, Chakravartty A1, Rodriguez-Lorenc K1, Taran T1, Jerusalem… Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer.